Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587275 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI
A Phase 2 study, sponsored by Ocera Therapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT00587275: Clinical Trial Phase 2 study, sponsored by Ocera Therapeutics.
NCT00587275 is a Phase 2 study that was terminated before completion, run by Ocera Therapeutics. The registered enrollment target is 4 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587275, a Phase 2 study, was terminated before completion, sponsored by Ocera Therapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this project is to test how safe and how well AST-120, an investigational product, works in treating too much acid in the stomach. Patients will be randomly assigned to one of two groups, AST-120 or a placebo for the first four weeks of the study. The patients will be switched to the other group (AST-120 or placebo)for the following four weeks.
Interventions
- DRUG AST-120
- DRUG Celphere CP-305
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
Why NCT00587275 stopped before completion
NCT00587275 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which AST-120 is the first listed.
NCT00587275 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00587275 about?
NCT00587275 is a clinical study titled "Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI". The purpose of this project is to test how safe and how well AST-120, an investigational product, works in treating too much acid in the stomach. Patients will be randomly assigned to one of two groups, AST-120 or a placebo for the first four weeks of the study. The patients will be switched to the ...
What is the current status of trial NCT00587275?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2007-10. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00587275?
The interventions under investigation include: AST-120 (DRUG), Celphere CP-305 (DRUG).
Who is sponsoring clinical trial NCT00587275?
This trial is sponsored by Ocera Therapeutics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00587275's enrollment target sits among peer trials
4 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia